The Expert Consensus for the Clinical Application of Autologous Bone Marrow Enrichment Technique for Bone Repair Technology ( version 2023), hosted by Chinese Journal of Trauma, organized by Southwest Hospital of Army Medical University and co-organized by Chongqing FWS Medical Device Co., Ltd. The conference aims to summarize the latest research results, solve the clinical controversial issues, standardize and promote the new clinical technology, formulate expert consensus on the clinical scope, application method, safety, effectiveness and other scientific and technical issues of autologous bone marrow enriched bone repair technology based on the evidence-based medicine method and clinical research results of experts, and provide valuable evidence-based information for the clinical application of the technology, so as to promote the scientific, standardized, safe and efficient clinical application of the technology. standardized, safe and efficient clinical application.
The conference invited academician Zhang Yingze, advisor of the journal, Prof. Zhang Lianyang, editor-in-chief, Prof. Tang Peifu, deputy editor-in-chief, Prof. Du Dingyuan, deputy editor-in-chief, Prof. Liu Guodong, executive deputy editor-in-chief, Prof. Xu Jianzhong and Prof. Luo Fei from Southwest Hospital of Army Medical University and more than 50 experts from all over China to attend the conference.
Prof. Liu Guodong, Executive Deputy Editor-in-Chief of Chinese Journal of Trauma, presided over the conference.
Prof. Fei Luo briefly introduced the technical background and formulation process of this expert consensus, focusing on the clinical technical characteristics of autologous bone marrow for bone repair, the scope of application of autologous bone marrow-enriched bone repair technology, safety and clinical application technology, etc. He comprehensively introduced the 16 recommended opinions, sorted out the internal logic of the recommended opinions, and explained the evidence sources of the recommended opinions.
Presentation by Prof. Luo Fei, Southwest Hospital, Army Medical University
Under the auspices of Prof. Liu Guodong, renowned professors such as Xu Jianzhong, Zhou Yue, Zhang Lianyang, Ye Zhaoming, Huang Wei, Hou Zhiyong, Fan Shunwu, Xu Yongqing and Luo Fei pressed the start button one after another on the stage and the Expert Consensus on Clinical Application of Autologous Bone Marrow Enrichment Bone Repair Technology (2023 Edition) was officially released.
Group photo of experts at the meeting
Product Summary
Bone Marrow Concentrator:
Bone defects caused by infection, tumors, trauma and other factors are very common in clinical practice, and there is a huge demand for bone graft materials for its treatment.
Bone repair materials need good conductivity and osteoinductivity. Autologous bone grafting is the gold standard, and complications such as extra trauma caused by autologous bone extraction, limited bone extraction, pain in the bone extraction area, hematoma, fracture, infection and other complications are common; Although bone repair materials such as allogeneic bone, hydroxyapatite (HA), and tricalcium phosphate (TCP) have been used in clinics, due to the lack of osteogenic bioactive components of these materials, their osteogenic activity is poor.
It has been clinically proven that a large number of stem cells and osteogenesis-related growth factors contained in autologous red bone marrow have the ability to promote bone repair. According to this principle, the bone growth negative pressure enrichment device can quickly enrich the effective bone formation components such as stem cells and growth factors in the patient's autologous bone marrow into the bone repair material during the operation, so that it has the biological activity of autologous bone.
A large number of research reports, animal experiments and clinical cases have proved that this technology can significantly improve the biological activity of bone graft materials and increase the bone fusion rate.
